Author

M. Aubry

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

D. Gilot· 2 shared R. Pineau· 2 shared A. Chatziioannou· 1 shared A. Etcheverry· 1 shared A. Jouannic· 1 shared A. L'Haridon· 1 shared A. M. Gorman· 1 shared A. M. Quemener· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Gilot

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma

P. Papoutsoglou, C. Louis, R. Pineau, A. L'Haridon, J. M. Banales, D. Gilot, M. Aubry, C. Coulouarn

This study identifies LINC00313 as a TGFβ-induced lncRNA that activates Wnt signaling and promotes cholangiocarcinoma through interactions with SWI/SNF and regulation of TCF7 and SULF2.

bioRxiv · Sep 28, 2022 · PreprintCancer Biology

Genomic characteristics and clinical significance of CD56+ Circulating Tumor Cells in Small Cell Lung Carcinoma

C. Ricordel, L. Chaillot, E.-I. Vlachavas, M. Logotheti, A. Jouannic, T. Desvallees, G. Lecuyer, M. Aubry, G. Kontogianni, C. Mastrokalou, F. Jouan, U. Jarry, R. Corre, Y. Le Guen, T. Guillaudeux, , R. Pedeux

This study isolates and analyzes CD56+ circulating tumor cells in SCLC, finding they have distinct genomic features and are associated with disease extension.

bioRxiv · Apr 30, 2022Cancer Biology

Uveal Melanoma: a miR-16 disease?

A. M. Quemener, L. Bachelot, M. Aubry, S. Avner, D. Leclerc, G. Salbert, F. Cabillic, D. Decaudin, B. Mari, F. Mouriaux, M.-D. Galibert, D. Gilot

This study identifies miR-16's non-canonical role in uveal melanoma by sequestering sponge RNAs, leading to oncogene derepression and poor survival, with a sponge-signature outperforming current methods.

bioRxiv · Nov 30, 2021Cancer Biology

Local intracerebral Inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivo.

P.-J. Le Reste, R. Pineau, K. Voutetakis, J. Samal, G. Jegou, S. Lhomond, A. M. Gorman, A. Samali, J. B. Patterson, Q. Zeng, A. Pandit, M. AUBRY, N. Soriano, A. Etcheverry, J. Mosser, , e. chevet

The paper develops a novel immunocompetent GBM model to test the effect of IRE1 inhibition on treatment efficacy in vivo.

bioRxiv · Feb 20, 2020Cancer Biology